procyanidin b2 has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Boso, S; Freire-Garabal, M; Gago, P; García, C; Martínez, MC; Novio, S; Núñez-Iglesias, MJ; Pérez-Muñuzuri, ME; Santiago, JL | 1 |
Deb, M; Kar, S; Parbin, S; Patra, SK; Pradhan, N; Rakshit, M; Rath, SK; Sengupta, D; Shilpi, A | 1 |
2 other study(ies) available for procyanidin b2 and Breast Cancer
Article | Year |
---|---|
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.
Topics: Antineoplastic Agents; Biflavonoids; Breast Neoplasms; Catechin; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Male; MCF-7 Cells; Proanthocyanidins; Prostatic Neoplasms | 2021 |
Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer.
Topics: Amino Acid Sequence; Animals; Biflavonoids; Breast; Breast Neoplasms; Catechin; Cell Line, Tumor; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Humans; Mice; Molecular Docking Simulation; Molecular Sequence Data; Proanthocyanidins; Sequence Alignment | 2015 |